0002135564-26-000001.txt : 20260521 0002135564-26-000001.hdr.sgml : 20260521 20260521134329 ACCESSION NUMBER: 0002135564-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260521 DATE AS OF CHANGE: 20260521 EFFECTIVENESS DATE: 20260521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ViCardia Therapeutics, Inc. CENTRAL INDEX KEY: 0002135564 ORGANIZATION NAME: EIN: 263089291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-584772 FILM NUMBER: 261007460 BUSINESS ADDRESS: STREET 1: 530 BUSH STREET, SUITE 802 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-661-1234 MAIL ADDRESS: STREET 1: 530 BUSH STREET, SUITE 802 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 D 1 primary_doc.xml X0708 D LIVE 0002135564 ViCardia Therapeutics, Inc. 530 BUSH STREET, SUITE 802 SAN FRANCISCO CA CALIFORNIA 94108 415-661-1234 DELAWARE None None Corporation true Michael Kokesh 530 Bush Street, Suite 802 San Francisco CA CALIFORNIA 94108 Executive Officer President & Chief Executive Officer Biotechnology Decline to Disclose 06b false 2026-05-19 false true false 10000 700000 700000 0 false 1 0 0 0 false ViCardia Therapeutics, Inc. /s/ Michael Kokesh Michael Kokesh President & Chief Executive Officer 2026-05-21